Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Realty Income A Pref | O- | Nov 15, 2024 | 24.99 | 0.00 |
Realty Income REIT | O | Nov 15, 2024 | 56.54 | +0.84 |
Reaves Utilities ETF | UTES | Nov 15, 2024 | 65.61 | +1.05 |
Reaves Utility | UTG | Nov 15, 2024 | 33.40 | -0.06 |
Reborn Coffee | REBN | Nov 15, 2024 | 1.11 | -1.77 |
Recon Capital DAX Germany ETF | DAX | Nov 15, 2024 | 32.90 | +0.06 |
Recon Capital Nasdaq-100 Covere | QYLD | Nov 15, 2024 | 18.08 | -2.32 |
Recon Technology | RCON | Nov 15, 2024 | 2.02 | -12.17 |
Rectitude Holdings | RECT | Nov 15, 2024 | 3.44 | -1.72 |
Recursion Pharmaceuticals A | RXRX | Nov 15, 2024 | 6.17 | -10.64 |
Red Cat | RCAT | Nov 15, 2024 | 4.70 | +16.92 |
Red River Bancshares | RRBI | Nov 15, 2024 | 58.27 | -0.31 |
Red Robin Gourmet Burgers | RRGB | Nov 15, 2024 | 5.22 | +1.75 |
Red Rock Resorts A | RRR | Nov 15, 2024 | 50.84 | +1.25 |
Red Violet | RDVT | Nov 15, 2024 | 32.92 | -0.35 |
RDDT | Nov 15, 2024 | 124.78 | -5.38 | |
Redfin | RDFN | Nov 15, 2024 | 8.37 | -3.90 |
RedHill Biopharma ADR | RDHL | Nov 15, 2024 | 7.29 | +4.29 |
Redwire | RDW | Nov 15, 2024 | 10.39 | +1.37 |
Redwood Trust | RWT-A | Nov 15, 2024 | 25.84 | -0.04 |
Redwood Trust | RWT | Nov 15, 2024 | 7.06 | +0.28 |
REE Automotive A | REE | Nov 15, 2024 | 6.97 | -4.26 |
Regal Rexnord | RRX | Nov 15, 2024 | 169.73 | -1.60 |
Regency Centers | REG | Nov 15, 2024 | 73.66 | 0.00 |
Regency Centers A Pref | REGCP | Nov 15, 2024 | 24.50 | +0.74 |
Regency Centers B Pref | REGCO | Nov 15, 2024 | 23.96 | +0.04 |
Regeneron Pharmaceuticals | REGN | Nov 15, 2024 | 756.81 | -3.28 |
REGENXBIO | RGNX | Nov 15, 2024 | 9.63 | -13.55 |
Regional Health Properties | RHE | Nov 15, 2024 | 1.57 | +12.14 |
Regional Health Properties A Pref | RHE-A | Nov 15, 2024 | 0.45 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.